Oxford Immunotec
(OXFD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 19,588 | 14,789 | 15,367 | 16,050 | 16,657 |
| Cost of Goods | 5,400 | 4,228 | 3,956 | 4,573 | 4,538 |
| Gross Profit | 14,188 | 10,561 | 11,411 | 11,477 | 12,119 |
| Operating Expenses | 15,569 | 14,138 | 16,650 | 17,103 | 16,676 |
| Operating Income | -981 | -3,349 | -4,283 | -5,053 | -4,019 |
| Other Income | 1,495 | 316 | -1,503 | -720 | -1,080 |
| Pre-tax Income | 514 | -3,033 | -5,786 | -5,773 | -5,099 |
| Income Tax | -76 | -1,537 | -38,468 | 485 | 634 |
| Net Income Continuous | 590 | -1,496 | 32,682 | -6,258 | -5,733 |
| Net Income Discontinuous | N/A | N/A | 108,378 | 2,774 | -738 |
| Net Income | $590 | $-1,496 | $141,060 | $-3,484 | $-6,471 |
| EPS Basic Total Ops | 0.02 | -0.06 | 5.43 | -0.13 | -0.25 |
| EPS Basic Continuous Ops | 0.02 | -0.06 | 1.26 | -0.24 | -0.22 |
| EPS Basic Discontinuous Ops | N/A | N/A | 4.17 | 0.11 | -0.03 |
| EPS Diluted Total Ops | 0.02 | -0.06 | 5.36 | -0.13 | -0.25 |
| EPS Diluted Continuous Ops | 0.02 | -0.06 | 1.25 | -0.24 | -0.22 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 4.10 | 0.11 | -0.03 |
| EPS Diluted Before Non-Recurring Items | 0.02 | -0.06 | N/A | N/A | N/A |
| EBITDA(a) | $-651 | $-2,879 | $-1,587 | $-4,616 | $-3,563 |